Unveiling the Emerging Role of Xanthine Oxidase in Acute Pancreatitis: Beyond Reactive Oxygen Species
Acute pancreatitis (AP) is a potentially fatal acute digestive disease that is widespread globally. Although significant progress has been made in the previous decade, the study of mechanisms and therapeutic strategies is still far from being completed. Xanthine oxidase (XO) is an enzyme that cataly...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Antioxidants |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3921/14/1/95 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832589272167743488 |
|---|---|
| author | Chenxia Han Yaling Wu Juan Rong Qing Xia Dan Du |
| author_facet | Chenxia Han Yaling Wu Juan Rong Qing Xia Dan Du |
| author_sort | Chenxia Han |
| collection | DOAJ |
| description | Acute pancreatitis (AP) is a potentially fatal acute digestive disease that is widespread globally. Although significant progress has been made in the previous decade, the study of mechanisms and therapeutic strategies is still far from being completed. Xanthine oxidase (XO) is an enzyme that catalyzes hypoxanthine and xanthine to produce urate and is accompanied by the generation of reactive oxygen species (ROS) in purine catabolism. Considerable preclinical and clinical studies have been conducted over many decades to investigate the role of XO in the pathogenesis of AP and its potential targeting therapeutic value. There is no doubt that the ROS generated by irreversibly activated XO participates in the local pancreas and multiple organ failure during AP. However, the optimal timing and doses for therapeutic interventions targeting XO in animal studies and the clinic, as well as the additional molecular mechanisms through which XO contributes to disease onset and progression, including metabolic regulation, remain to be elucidated. This review summarized the benefits and contradictions of using XO inhibitors in animal models, offered mechanisms other than ROS, and discussed the difficulties faced in clinical trials. We hope to provide a perspective on the future worthwhile basic and clinical research on XO by analyzing its chemical and biological characteristics, as well as the progress of its regulatory mechanisms in AP. |
| format | Article |
| id | doaj-art-80b6471d8f6143919dcd8db621daf96a |
| institution | Kabale University |
| issn | 2076-3921 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Antioxidants |
| spelling | doaj-art-80b6471d8f6143919dcd8db621daf96a2025-01-24T13:19:28ZengMDPI AGAntioxidants2076-39212025-01-011419510.3390/antiox14010095Unveiling the Emerging Role of Xanthine Oxidase in Acute Pancreatitis: Beyond Reactive Oxygen SpeciesChenxia Han0Yaling Wu1Juan Rong2Qing Xia3Dan Du4West China Centre of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, ChinaFrontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, ChinaDepartment of Gastroenterology, The Third People’s Hospital of Chengdu, Chengdu 610031, ChinaWest China Centre of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, ChinaFrontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, ChinaAcute pancreatitis (AP) is a potentially fatal acute digestive disease that is widespread globally. Although significant progress has been made in the previous decade, the study of mechanisms and therapeutic strategies is still far from being completed. Xanthine oxidase (XO) is an enzyme that catalyzes hypoxanthine and xanthine to produce urate and is accompanied by the generation of reactive oxygen species (ROS) in purine catabolism. Considerable preclinical and clinical studies have been conducted over many decades to investigate the role of XO in the pathogenesis of AP and its potential targeting therapeutic value. There is no doubt that the ROS generated by irreversibly activated XO participates in the local pancreas and multiple organ failure during AP. However, the optimal timing and doses for therapeutic interventions targeting XO in animal studies and the clinic, as well as the additional molecular mechanisms through which XO contributes to disease onset and progression, including metabolic regulation, remain to be elucidated. This review summarized the benefits and contradictions of using XO inhibitors in animal models, offered mechanisms other than ROS, and discussed the difficulties faced in clinical trials. We hope to provide a perspective on the future worthwhile basic and clinical research on XO by analyzing its chemical and biological characteristics, as well as the progress of its regulatory mechanisms in AP.https://www.mdpi.com/2076-3921/14/1/95xanthine oxidaseacute pancreatitisdrug targetcellular mechanismmultiple organ failure |
| spellingShingle | Chenxia Han Yaling Wu Juan Rong Qing Xia Dan Du Unveiling the Emerging Role of Xanthine Oxidase in Acute Pancreatitis: Beyond Reactive Oxygen Species Antioxidants xanthine oxidase acute pancreatitis drug target cellular mechanism multiple organ failure |
| title | Unveiling the Emerging Role of Xanthine Oxidase in Acute Pancreatitis: Beyond Reactive Oxygen Species |
| title_full | Unveiling the Emerging Role of Xanthine Oxidase in Acute Pancreatitis: Beyond Reactive Oxygen Species |
| title_fullStr | Unveiling the Emerging Role of Xanthine Oxidase in Acute Pancreatitis: Beyond Reactive Oxygen Species |
| title_full_unstemmed | Unveiling the Emerging Role of Xanthine Oxidase in Acute Pancreatitis: Beyond Reactive Oxygen Species |
| title_short | Unveiling the Emerging Role of Xanthine Oxidase in Acute Pancreatitis: Beyond Reactive Oxygen Species |
| title_sort | unveiling the emerging role of xanthine oxidase in acute pancreatitis beyond reactive oxygen species |
| topic | xanthine oxidase acute pancreatitis drug target cellular mechanism multiple organ failure |
| url | https://www.mdpi.com/2076-3921/14/1/95 |
| work_keys_str_mv | AT chenxiahan unveilingtheemergingroleofxanthineoxidaseinacutepancreatitisbeyondreactiveoxygenspecies AT yalingwu unveilingtheemergingroleofxanthineoxidaseinacutepancreatitisbeyondreactiveoxygenspecies AT juanrong unveilingtheemergingroleofxanthineoxidaseinacutepancreatitisbeyondreactiveoxygenspecies AT qingxia unveilingtheemergingroleofxanthineoxidaseinacutepancreatitisbeyondreactiveoxygenspecies AT dandu unveilingtheemergingroleofxanthineoxidaseinacutepancreatitisbeyondreactiveoxygenspecies |